SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 210 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,092,000 | +66.0% | 114,440 | +146.6% | 0.06% | +140.7% |
| Q2 2018 | $658,000 | -77.6% | 46,406 | -69.9% | 0.03% | -77.1% |
| Q1 2018 | $2,933,000 | +163.8% | 154,406 | +127.7% | 0.12% | +140.8% |
| Q4 2017 | $1,112,000 | +334.4% | 67,806 | +132.6% | 0.05% | +250.0% |
| Q2 2017 | $256,000 | +59.0% | 29,146 | -45.1% | 0.01% | +40.0% |
| Q4 2016 | $161,000 | -54.9% | 53,046 | -10.3% | 0.01% | -37.5% |
| Q1 2016 | $357,000 | -24.7% | 59,119 | +13.6% | 0.02% | -27.3% |
| Q4 2015 | $474,000 | -11.7% | 52,019 | +7.4% | 0.02% | +22.2% |
| Q2 2015 | $537,000 | -77.9% | 48,439 | -68.7% | 0.02% | -78.6% |
| Q1 2015 | $2,428,000 | +572.6% | 154,849 | +552.3% | 0.08% | +546.2% |
| Q4 2014 | $361,000 | +64.1% | 23,739 | +16.1% | 0.01% | +30.0% |
| Q3 2014 | $220,000 | -86.9% | 20,451 | -81.5% | 0.01% | -88.6% |
| Q2 2014 | $1,685,000 | +80.4% | 110,352 | +113.5% | 0.09% | +79.6% |
| Q1 2014 | $934,000 | +44.1% | 51,682 | -16.4% | 0.05% | +40.0% |
| Q3 2013 | $648,000 | +62.4% | 61,852 | +20.9% | 0.04% | +169.2% |
| Q2 2013 | $399,000 | – | 51,153 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIC CAPITAL INC | 875,284 | $2,670,000 | 1.34% |
| NEXTHERA CAPITAL LP | 503,000 | $1,534,000 | 0.90% |
| Opaleye Management Inc. | 400,000 | $1,220,000 | 0.72% |
| WASATCH ADVISORS LP | 7,256,260 | $22,132,000 | 0.33% |
| Cormorant Asset Management, LP | 650,000 | $1,983,000 | 0.27% |
| Sicart Associates LLC | 101,950 | $311,000 | 0.22% |
| Baker Brothers Advisors | 4,055,876 | $12,370,000 | 0.12% |
| Leisure Capital Management | 43,008 | $131,000 | 0.12% |
| Piermont Capital Management Inc. | 165,569 | $505,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 837,963 | $2,556,000 | 0.10% |